Overview Dividends

(VRSK) Verisk Analytics - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92345Y1064

Data Analytics, Risk Assessment, Claims Solutions, Underwriting Tools

VRSK EPS (Earnings per Share)

EPS Growth (3Y CAGR): -56.93%
EPS Trend (3Y Correlation): -28.5%

VRSK Revenue

Revenue Growth (3Y CAGR): 8.97%
Revenue Trend (3Y Correlation): 56.6%

Description: VRSK Verisk Analytics

Verisk Analytics, Inc. (NASDAQ:VRSK) provides data-driven analytics and technology platforms to insurers worldwide, covering underwriting, claims, fraud detection, catastrophe modeling, and specialty reinsurance workflows. Its product suite spans underwriting forms, rating rules, loss-cost services, life-insurance workflow automation, property-damage estimating tools, and international claims solutions for personal injury and motor franchises.

In FY 2023 the company generated roughly $2.9 billion in revenue, with the data-analytics segment delivering a 10 % year-over-year growth rate and an operating margin near 24 %. Key macro drivers include rising insurance loss costs tied to increasing frequency of extreme weather events-fueling demand for Verisk’s catastrophe-modeling services-and heightened regulatory scrutiny that pushes insurers toward more sophisticated compliance and fraud-detection tools. Additionally, the broader insurtech trend of digitizing underwriting workflows supports recurring revenue expansion for Verisk’s subscription-based offerings.

For a deeper dive into Verisk’s valuation metrics and scenario analyses, you might explore the ValueRay platform, which aggregates analyst forecasts and comparable peer data to help you assess the stock’s risk-adjusted upside.

VRSK Stock Overview

Market Cap in USD	33,709m
Sub-Industry	Research & Consulting Services
IPO / Inception	2009-10-07

VRSK Stock Ratings

Growth Rating	37.5%
Fundamental	78.8%
Dividend Rating	59.4%
Return 12m vs S&P 500	-23.0%
Analyst Rating	3.39 of 5

VRSK Dividends

Dividend Yield 12m	0.73%
Yield on Cost 5y	0.95%
Annual Growth 5y	9.63%
Payout Consistency	100.0%
Payout Ratio	25.3%

VRSK Growth Ratios

Growth Correlation 3m	-85.1%
Growth Correlation 12m	-16.3%
Growth Correlation 5y	82.4%
CAGR 5y	11.83%
CAGR/Max DD 3y (Calmar Ratio)	0.42
CAGR/Mean DD 3y (Pain Ratio)	2.52
Sharpe Ratio 12m	-0.80
Alpha	-24.70
Beta	0.856
Volatility	26.16%
Current Volume	982k
Average Volume 20d	1099.1k
Stop Loss	230.3 (-3%)
Signal	0.12

Piotroski VR‑10 (Strict, 0-10) 9.0

Net Income (915.9m TTM) > 0 and > 6% of Revenue (6% = 179.2m TTM)

FCFTA 0.21 (>2.0%) and ΔFCFTA 3.18pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 16.01% (prev -2.31%; Δ 18.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.26 (>3.0%) and CFO 1.24b > Net Income 915.9m (YES >=105%, WARN >=100%)

Net Debt (2.80b) to EBITDA (1.64b) ratio: 1.71 <= 3.0 (WARN <= 3.5)

Current Ratio 1.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (140.3m) change vs 12m ago -2.06% (target <= -2.0% for YES)

Gross Margin 69.39% (prev 67.91%; Δ 1.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 62.46% (prev 58.21%; Δ 4.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 9.56 (EBITDA TTM 1.64b / Interest Expense TTM 138.4m) >= 6 (WARN >= 3)

Altman Z'' 9.41

(A) 0.10 = (Total Current Assets 1.38b - Total Current Liabilities 899.4m) / Total Assets 4.79b

(B) 1.57 = Retained Earnings (Balance) 7.51b / Total Assets 4.79b

warn (B) unusual magnitude: 1.57 — check mapping/units

(D) 1.70 = Book Value of Equity 7.63b / Total Liabilities 4.48b

Total Rating: 9.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 78.79

1. Piotroski 9.0pt = 4.0

2. FCF Yield 2.79% = 1.40

3. FCF Margin 34.17% = 7.50

4. Debt/Equity 11.00 = -2.50

5. Debt/Ebitda 1.71 = 0.57

6. ROIC - WACC (= 21.23)% = 12.50

7. RoE 439.1% = 2.50

8. Rev. Trend 56.58% = 4.24

9. EPS Trend -28.50% = -1.42

What is the price of VRSK shares?

As of October 23, 2025, the stock is trading at USD 237.47 with a total of 981,994 shares traded.
Over the past week, the price has changed by -2.67%, over one month by -2.75%, over three months by -20.21% and over the past year by -10.72%.

Is Verisk Analytics a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Verisk Analytics (NASDAQ:VRSK) is currently (October 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 78.79 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VRSK is around 211.68 USD . This means that VRSK is currently overvalued and has a potential downside of -10.86%.

Is VRSK a buy, sell or hold?

Verisk Analytics has received a consensus analysts rating of 3.39. Therefor, it is recommend to hold VRSK.

Strong Buy: 3
Buy: 3
Hold: 10
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the VRSK price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	303.9	28%
Analysts Target Price	303.9	28%
ValueRay Target Price	235.8	-0.7%

Last update: 2025-10-11 03:57

VRSK Fundamental Data Overview

Market Cap USD = 33.71b (33.71b USD * 1.0 USD.USD)
P/E Trailing = 37.4643
P/E Forward = 31.25
P/S = 11.2871
P/B = 110.9069
P/EG = 2.9688
Beta = 0.856
Revenue TTM = 2.99b USD
EBIT TTM = 1.32b USD
EBITDA TTM = 1.64b USD
Long Term Debt = 3.21b USD (from longTermDebt, last quarter)
Short Term Debt = 44.8m USD (from shortTermDebt, last quarter)
Debt = 3.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.80b USD (from netDebt column, last quarter)
Enterprise Value = 36.51b USD (33.71b + Debt 3.43b - CCE 628.7m)
Interest Coverage Ratio = 9.56 (Ebit TTM 1.32b / Interest Expense TTM 138.4m)
FCF Yield = 2.79% (FCF TTM 1.02b / Enterprise Value 36.51b)
FCF Margin = 34.17% (FCF TTM 1.02b / Revenue TTM 2.99b)
Net Margin = 30.67% (Net Income TTM 915.9m / Revenue TTM 2.99b)
Gross Margin = 69.39% ((Revenue TTM 2.99b - Cost of Revenue TTM 914.2m) / Revenue TTM)
Gross Margin QoQ = 70.30% (prev 69.35%)
Tobins Q-Ratio = 7.61 (Enterprise Value 36.51b / Total Assets 4.79b)
Interest Expense / Debt = 1.04% (Interest Expense 35.5m / Debt 3.43b)
Taxrate = 22.75% (74.6m / 327.9m)
NOPAT = 1.02b (EBIT 1.32b * (1 - 22.75%))
Current Ratio = 1.53 (Total Current Assets 1.38b / Total Current Liabilities 899.4m)
Debt / Equity = 11.00 (Debt 3.43b / totalStockholderEquity, last quarter 311.7m)
Debt / EBITDA = 1.71 (Net Debt 2.80b / EBITDA 1.64b)
Debt / FCF = 2.74 (Net Debt 2.80b / FCF TTM 1.02b)
Total Stockholder Equity = 208.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.10% (Net Income 915.9m / Total Assets 4.79b)
RoE = 439.1% (Net Income TTM 915.9m / Total Stockholder Equity 208.6m)
RoCE = 38.67% (EBIT 1.32b / Capital Employed (Equity 208.6m + L.T.Debt 3.21b))
RoIC = 29.63% (NOPAT 1.02b / Invested Capital 3.45b)
WACC = 8.40% (E(33.71b)/V(37.14b) * Re(9.17%) + D(3.43b)/V(37.14b) * Rd(1.04%) * (1-Tc(0.23)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.75%
[DCF Debug] Terminal Value 75.72% ; FCFE base≈957.4m ; Y1≈1.05b ; Y5≈1.33b
Fair Price DCF = 135.6 (DCF Value 18.95b / Shares Outstanding 139.7m; 5y FCF grow 10.83% → 3.0% )
EPS Correlation: -28.50 | EPS CAGR: -56.93% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.58 | Revenue CAGR: 8.97% | SUE: 0.54 | # QB: 0

Additional Sources for VRSK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle